BidaskClub lowered shares of athenahealth, Inc. (NASDAQ:ATHN) from a hold rating to a sell rating in a report released on Wednesday.

Several other equities research analysts also recently weighed in on the company. Jefferies Group LLC reissued a sell rating and set a $95.00 price objective on shares of athenahealth in a report on Friday, March 24th. Citigroup Inc. set a $128.00 target price on athenahealth and gave the stock a buy rating in a research report on Monday, May 1st. Cantor Fitzgerald reaffirmed a buy rating and set a $118.00 target price (down from $135.00) on shares of athenahealth in a research report on Thursday, April 27th. Piper Jaffray Companies reaffirmed an overweight rating and set a $160.00 target price on shares of athenahealth in a research report on Tuesday, April 4th. Finally, Evercore ISI reaffirmed an outperform rating and set a $147.00 target price (up from $118.00) on shares of athenahealth in a research report on Friday, May 19th. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and twelve have issued a buy rating to the company’s stock. The company presently has a consensus rating of Hold and a consensus price target of $139.81.

Shares of athenahealth (ATHN) opened at 141.97 on Wednesday. athenahealth has a one year low of $90.11 and a one year high of $149.55. The firm has a market cap of $5.66 billion, a price-to-earnings ratio of 279.47 and a beta of 1.79. The stock’s 50 day moving average price is $135.17 and its 200 day moving average price is $119.14.

athenahealth (NASDAQ:ATHN) last released its quarterly earnings data on Thursday, April 27th. The health services provider reported $0.10 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.11 by $0.01. athenahealth had a net margin of 1.84% and a return on equity of 5.93%. The firm had revenue of $285.40 million for the quarter, compared to analyst estimates of $296.49 million. During the same period last year, the business earned $0.34 EPS. The company’s revenue was up 11.4% compared to the same quarter last year. On average, equities analysts anticipate that athenahealth will post $1.86 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “athenahealth, Inc. (ATHN) Rating Lowered to Sell at BidaskClub” was originally posted by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another website, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/07/17/athenahealth-inc-athn-rating-lowered-to-sell-at-bidaskclub.html.

In other athenahealth news, SVP Jonathan D. Porter sold 300 shares of the company’s stock in a transaction dated Monday, May 15th. The shares were sold at an average price of $109.48, for a total transaction of $32,844.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Jonathan Bush sold 8,000 shares of the company’s stock in a transaction dated Tuesday, April 25th. The shares were sold at an average price of $120.00, for a total transaction of $960,000.00. Following the sale, the chief executive officer now owns 319,807 shares of the company’s stock, valued at $38,376,840. The disclosure for this sale can be found here. Insiders sold 25,383 shares of company stock valued at $3,286,932 over the last quarter. 3.20% of the stock is owned by company insiders.

A number of hedge funds have recently bought and sold shares of the stock. BlackRock Inc. raised its stake in athenahealth by 30,642.6% in the first quarter. BlackRock Inc. now owns 1,599,847 shares of the health services provider’s stock valued at $180,286,000 after buying an additional 1,594,643 shares during the last quarter. Morgan Stanley raised its stake in athenahealth by 9.7% in the first quarter. Morgan Stanley now owns 4,514,305 shares of the health services provider’s stock worth $508,717,000 after buying an additional 397,837 shares in the last quarter. Clearbridge Investments LLC raised its stake in athenahealth by 61.8% in the first quarter. Clearbridge Investments LLC now owns 908,505 shares of the health services provider’s stock worth $102,379,000 after buying an additional 347,133 shares in the last quarter. Camber Capital Management LLC purchased a new stake in athenahealth during the fourth quarter worth $31,551,000. Finally, Credit Suisse AG raised its stake in athenahealth by 404.5% in the first quarter. Credit Suisse AG now owns 300,420 shares of the health services provider’s stock worth $33,854,000 after buying an additional 240,876 shares in the last quarter.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.